GGTLC3 and exocrine pancreatic carcinoma: In 1974, New York physician Dr. Lum reported that serum GGT was several times the upper limit of normal in patients with biopsy‐confirmed metastatic hepatocellular carcinoma, pancreatic carcinoma, and gallbladder cancer.